BIMI International Medical Inc · OTC:BIMI

BIMI International Medical Inc financial statements

BIMI International Medical Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue12.6M11.8M21.3M12.8M158.0K6.54M8.51M6.04M6.71M9.98M
Cost of revenue7.54M9.88M18.9M10.4M304.1K6.08M7.59M5.89M5.54M8.50M
Gross profit5.09M1.95M2.43M2.44M-146.0K459.4K916.5K148.8K1.18M1.48M
Research and development56.2K73.2K96.6K105.2K107.9K
Selling, general and administrative8.91M10.6M6.06M5.47M986.0K16.1M2.05M1.59M1.72M1.83M
Operating income-3.82M-15.3M-8.11M-3.81M-986.0K-15.8M-1.20M-1.48M-641.0K-376.0K
Depreciation and amortization248.7K223.6K244.1K56.0K262.0K1.04M944.0K998.2K1.27M844.7K
EBITDA-3.57M-15.1M-7.86M-3.76M-724.0K-14.8M-251.0K-481.8K632.8K468.7K
Interest expense1.09M3.43M2.44M84.9K6.35K416.4K353.7K354.4K398.6K420.9K
Income before tax-10.6M-21.6M-34.7M-3.35M-1.54M-17.0M-1.58M-1.82M-1.01M-552.0K
Income tax6.09K29.7K434.3K1171172.74K246-40.3K64.9K
Net income-10.5M-22.4M-35.0M-5.29M-4.44M-16.8M-1.57M-1.82M-969.0K-617.0K
Earnings per share, basic-8.40-65.24-24.80-27.17-2.22-11.10-13.82-7.73-5.44

Balance sheet

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents2.34M4.80M135.3K36.4K17.9K282.2K124.6K434.6K1.30M
Receivables4.18M6.07M8.34M10.1K1.34M16.4M7.27M8.27M9.10M
Inventory7.65M5.15M735.4K707.5K938.0K2.06M4.61M7.05M5.62M
Current assets23.2M21.2M25.2M22.0M2.61M18.8M15.1M19.6M18.8M
Property, plant and equipment8.37M910.2K38.6K18.0M20.0M19.6M22.0M26.4M
Goodwill2.07M8.38M6.91M0
Total assets35.7M38.1M33.2M30.1M23.1M41.4M37.3M44.4M48.3M
Accounts payable10.8M5.20M5.85M3.20M7.25M3.98M3.40M4.88M5.81M
Current liabilities25.4M22.1M15.6M21.5M13.1M14.1M10.6M14.0M17.0M
Long-term debt314.8K538.0K721.0K
Total debt5.46M8.73M5.03M107.4K5.82M7.22M5.76M8.06M9.95M
Total liabilities30.5M26.8M16.3M21.5M13.1M14.1M10.6M14.0M17.0M
Shareholders' equity4.05M11.2M16.7M8.68M9.99M27.2M26.7M30.4M31.3M
Shares outstanding2.67M536.3K213.5K163.4K7.57M141.5K131.5K125.3K113.4K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-2.90M-10.3M-1.28M-3.52M-2.06M-344.0K-908.2K159.8K-2.47M-995.1K
Capital spending00-814.7K-259.0K-259.0K-259.0K-259.0K-407.5K-663.3K-341.6K
Free cash flow-3.50M-10.3M-2.09M-3.78M-2.06M-344.0K-908.2K-247.7K-3.14M-1.34M
Cash from investing-536.9K-696.5K-724.5K166.7K166.7K166.7K-407.5K1.59M-341.6K
Cash from financing3.14M8.43M6.88M3.99M1.84M211.3K1.05M-45.2K48.3K1.63M
Share buybacks3.09M500.0K16.5K
Change in cash-6.21K-2.27M4.66M133.7K36.7K-84.8K157.5K-309.9K-869.6K283.4K